Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism of Delayed Neutrophil Apoptosis in Acute Lung Injury: Effects of Ginsenoside Derivatives on the Improvement of Delayed Neutrophil Apoptosis

NCT04607434 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT04607434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04607434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism of Delayed Neutrophil Apoptosis in Acute Lung Injury: Effects of Ginsenoside Derivatives on the Improvement of Delayed Neutrophil Apoptosis
Lead sponsor
The First Hospital of Jilin University
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
February 1, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury/acute respiratory distress syndrome (ards), apoptosis, immunosuppression, neutrophils, pathogenesis